The price of branded prescription drugs will rise an average of 4.5% in 2025, the same increase as was seen in 2024, ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor ...

A newly approved drug, atogepant, may start reducing migraines on the very first day of use, according to a study published ...

Ubrelvy is a brand-name tablet prescribed for acute (immediate and short term) migraine ... This list doesn’t include all possible mild side effects of the drug. For more information, you ...

The U.S. pays more for prescription ... including migraine treatment Nurtec and cancer drugs Adcetris, Ibrance and Xeljanz between 3% and 5%. "Pfizer has adjusted the average list prices of ...